{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:03:35Z","timestamp":1794855815153,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01875-w","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:31:56Z","timestamp":1785825116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PGK1-driven histone lactylation fuels MDSC-driven immune evasion and tumor progression in triple-negative breast cancer"],"prefix":"10.1038","author":[{"given":"Yong-peng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-zhen","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudagula","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-lie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"1875_CR1","doi-asserted-by":"crossref","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics. Ca. 2025;75: 10.","DOI":"10.3322\/caac.21871"},{"key":"1875_CR2","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies. Lancet. 2017;389:2430\u201342.","journal-title":"Lancet"},{"key":"1875_CR3","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13:4429\u201334.","journal-title":"Clin Cancer Res"},{"key":"1875_CR4","doi-asserted-by":"publisher","first-page":"vi46","DOI":"10.1093\/annonc\/mds195","volume":"23","author":"F Andre","year":"2012","unstructured":"Andre F, Zielinski C. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents. Ann Oncol. 2012;23:vi46\u201351.","journal-title":"Ann Oncol"},{"key":"1875_CR5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/cancers16020466","volume":"16","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P. Targeted therapies and drug resistance in advanced breast cancer, alternative strategies and the way beyond. Cancers. 2024;16:466.","journal-title":"Cancers"},{"key":"1875_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","volume":"16","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Song B, Yi M, Yan Y, Mei Q, et al. Recent advances in targeted strategies for triple-negative breast cancer. J Hematol Oncol. 2023;16:100.","journal-title":"J Hematol Oncol"},{"key":"1875_CR7","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1200\/JCO.2015.64.8931","volume":"34","author":"R Nanda","year":"2016","unstructured":"Nanda R, Chow LQ, Dees EC, Berger R, Gupta S, Geva R, et al. Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study. J Clin Oncol. 2016;34:2460\u20137.","journal-title":"J Clin Oncol"},{"key":"1875_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pag\u00e9s M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Rev Clin Oncol. 2017;14:11\u201331.","journal-title":"Nat Rev Clin Oncol"},{"key":"1875_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PD, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591:645\u201351.","journal-title":"Nature"},{"key":"1875_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-019-0804-8","volume":"12","author":"L Yang","year":"2019","unstructured":"Yang L, Li A, Lei Q, Zhang Y. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J Hematol Oncol. 2019;12:125.","journal-title":"J Hematol Oncol"},{"key":"1875_CR11","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, Drijvers JM, Baker GJ, Catozzi A, Garc\u00eda-Ca\u00f1averas JC, Gassaway BM, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183:1848\u201366.e26.","journal-title":"Cell"},{"key":"1875_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","volume":"617","author":"H Yuan","year":"2023","unstructured":"Yuan H, Wu X, Wu Q, Chatoff A, Megill E, Gao J, et al. Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature. 2023;617:818\u201326.","journal-title":"Nature"},{"key":"1875_CR13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/j.cmet.2022.08.002","volume":"34","author":"D Guo","year":"2022","unstructured":"Guo D, Tong Y, Jiang X, Meng Y, Jiang H, Du L, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of I\u03baB\u03b1. Cell Metab. 2022;34:1312\u201324.e6.","journal-title":"Cell Metab"},{"key":"1875_CR14","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1136\/gutjnl-2022-329349","volume":"72","author":"X Liu","year":"2023","unstructured":"Liu X, Tang R, Xu J, Tan Z, Liang C, Meng Q, et al. CRIP1 fosters MDSC trafficking and resets tumour microenvironment via facilitating NF-\u03baB\/p65 nuclear translocation in pancreatic ductal adenocarcinoma. Gut. 2023;72:2329\u201343.","journal-title":"Gut"},{"key":"1875_CR15","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","volume":"35","author":"L Wu","year":"2023","unstructured":"Wu L, Jin Y, Zhao X, Tang K, Zhao Y, Tong L, et al. Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1. Cell Metab. 2023;35:1580\u201396.e9.","journal-title":"Cell Metab"},{"key":"1875_CR16","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1158\/0008-5472.CAN-23-3513","volume":"84","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhou L, Zhang M, Du Y, Li C, Ren H, et al. H3K18 lactylation potentiates immune escape of non\u2013small cell lung cancer. Cancer Res. 2024;84:3589\u2013601.","journal-title":"Cancer Res"},{"key":"1875_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06943-9","volume":"15","author":"M Wang","year":"2024","unstructured":"Wang M, Wang T, Wang J, Yang Y, Li X, Chen H, et al. ALDH1A1 promotes immune escape of tumor cells through ZBTB7B-glycolysis pathway. Cell Death Dis. 2024;15:568.","journal-title":"Cell Death Dis"},{"key":"1875_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114686","volume":"43","author":"R Wang","year":"2024","unstructured":"Wang R, Li C, Cheng Z, Li M, Shi J, Zhang Z, et al. H3K9 lactylation in malignant cells facilitates CD8+ T cell dysfunction and poor immunotherapy response. Cell Rep. 2024;43:114686.","journal-title":"Cell Rep"},{"key":"1875_CR19","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41556-022-01002-x","volume":"24","author":"K-C Kao","year":"2022","unstructured":"Kao K-C, Vilbois S, Tsai C-H, Ho P-C. Metabolic communication in the tumour\u2013immune microenvironment. Nat Cell Biol. 2022;24:1574\u201383.","journal-title":"Nat Cell Biol"},{"key":"1875_CR20","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"1875_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, et al. Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma. Genome Biol. 2021;22:1\u201321.","journal-title":"Genome Biol"},{"key":"1875_CR22","doi-asserted-by":"publisher","first-page":"2309840","DOI":"10.1002\/advs.202309840","volume":"11","author":"B Chen","year":"2024","unstructured":"Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H, et al. Metabolic recoding of NSUN2-mediated m5C modification promotes the progression of colorectal cancer via the NSUN2\/YBX1\/m5C-ENO1 positive feedback loop. Adv Sci. 2024;11:2309840.","journal-title":"Adv Sci"},{"key":"1875_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02008-9","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Si W, Xia L, Yin D, Wei T, Tao M, et al. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma. Mol Cancer. 2024;23:90.","journal-title":"Mol Cancer"},{"key":"1875_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/15548627.2023.2249762","volume":"20","author":"W Li","year":"2024","unstructured":"Li W, Zhou C, Yu L, Hou Z, Liu H, Kong L, et al. Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 2024;20:114\u201330.","journal-title":"Autophagy"},{"key":"1875_CR25","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"Li F, Zhang H, Huang Y, Li D, Zheng Z, Xie K, et al. Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist Updat. 2024;73:101059.","journal-title":"Drug Resist Updat"},{"key":"1875_CR26","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1038\/s41590-024-01985-9","volume":"25","author":"D Raychaudhuri","year":"2024","unstructured":"Raychaudhuri D, Singh P, Chakraborty B, Hennessey M, Tannir AJ, Byregowda S, et al. Histone lactylation drives CD8+ T cell metabolism and function. Nat Immunol. 2024;25:2140\u201351.","journal-title":"Nat Immunol"},{"key":"1875_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2021.04.004","volume":"54","author":"S Hegde","year":"2021","unstructured":"Hegde S, Leader AM, Merad M. MDSC: markers, development, states, and unaddressed complexity. Immunity. 2021;54:875\u201384.","journal-title":"Immunity"},{"key":"1875_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01657-y","volume":"21","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yi M, Niu M, Mei Q, Wu K. Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy. Mol Cancer. 2022;21:184.","journal-title":"Mol Cancer"},{"key":"1875_CR29","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347.","journal-title":"Nat Genet"},{"key":"1875_CR30","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1002\/j.1460-2075.1982.tb01366.x","volume":"1","author":"H Watson","year":"1982","unstructured":"Watson H, Walker N, Shaw P, Bryant T, Wendell P, Fothergill L, et al. Sequence and structure of yeast phosphoglycerate kinase. EMBO J. 1982;1:1635\u201340.","journal-title":"EMBO J"},{"key":"1875_CR31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.molcel.2016.02.009","volume":"61","author":"X Li","year":"2016","unstructured":"Li X, Jiang Y, Meisenhelder J, Yang W, Hawke DH, Zheng Y, et al. Mitochondria-translocated PGK1 functions as a protein kinase to coordinate glycolysis and the TCA cycle in tumorigenesis. Mol Cell. 2016;61:705\u201319.","journal-title":"Mol Cell"},{"key":"1875_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, B\u00e6k M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1\u20133) are histone lysine delactylases. Sci Adv. 2022;8:eabi6696.","journal-title":"Sci Adv"},{"key":"1875_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01856-1","volume":"22","author":"B Xie","year":"2023","unstructured":"Xie B, Lin J, Chen X, Zhou X, Zhang Y, Fan M, et al. CircXRN2 suppresses tumor progression driven by histone lactylation through activating the Hippo pathway in human bladder cancer. Mol Cancer. 2023;22:151.","journal-title":"Mol Cancer"},{"key":"1875_CR34","unstructured":"Xu X, Dinges J, Hasvold LA, Longenecker KL, Ouyang X, Phillips GB (inventors). China Patent Agent (H.K.) Ltd, Abbott Laboratories, applicants. Phosphoglycerate kinase inhibitors. International patent WO2012045196A1. 2012."},{"key":"1875_CR35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2114851119","volume":"119","author":"R Zhang","year":"2022","unstructured":"Zhang R, Yang Y, Dong W, Lin M, He J, Zhang X, et al. D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proc Natl Acad Sci USA. 2022;119:e2114851119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1875_CR36","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","volume":"78","author":"JE Bader","year":"2020","unstructured":"Bader JE, Voss K, Rathmell JC. Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy. Mol Cell. 2020;78:1019\u201333.","journal-title":"Mol Cell"},{"key":"1875_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24:230\u201341.","journal-title":"Nat Cell Biol"},{"key":"1875_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi2465","volume":"9","author":"W Xiang","year":"2023","unstructured":"Xiang W, Lv H, Xing F, Sun X, Ma Y, Wu L, et al. Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation. Sci Adv. 2023;9:eadi2465.","journal-title":"Sci Adv"},{"key":"1875_CR39","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/s43018-023-00636-6","volume":"4","author":"KD Miller","year":"2023","unstructured":"Miller KD, O\u2019Connor S, Pniewski KA, Kannan T, Acosta R, Mirji G, et al. Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer. Nat Cancer. 2023;4:1491\u2013507.","journal-title":"Nat Cancer"},{"key":"1875_CR40","doi-asserted-by":"publisher","first-page":"2302498","DOI":"10.1002\/advs.202302498","volume":"10","author":"Q Chen","year":"2023","unstructured":"Chen Q, Yin H, He J, Xie Y, Wang W, Xu H, et al. Tumor microenvironment responsive CD8+ T cells and myeloid-derived suppressor cells to trigger CD73 inhibitor AB680-based synergistic therapy for pancreatic cancer. Adv Sci. 2023;10:2302498.","journal-title":"Adv Sci"},{"key":"1875_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39571-6","volume":"14","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Peng Y, Ji F, Chen H, Kang W, Chan LS, et al. Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer. Nat Commun. 2023;14:4677.","journal-title":"Nat Commun"},{"key":"1875_CR42","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCRESAHA.122.320488","volume":"131","author":"N Wang","year":"2022","unstructured":"Wang N, Wang W, Wang X, Mang G, Chen J, Yan X, et al. Histone lactylation boosts reparative gene activation post\u2013myocardial infarction. Circ Res. 2022;131:893\u2013908.","journal-title":"Circ Res"},{"key":"1875_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41422-023-00864-6","volume":"34","author":"Y Mao","year":"2024","unstructured":"Mao Y, Zhang J, Zhou Q, He X, Zheng Z, Wei Y, et al. Hypoxia induces mitochondrial protein lactylation to limit oxidative phosphorylation. Cell Res. 2024;34:13\u201330.","journal-title":"Cell Res"},{"key":"1875_CR44","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1016\/j.cell.2023.03.006","volume":"186","author":"P Sharma","year":"2023","unstructured":"Sharma P, Goswami S, Raychaudhuri D, Siddiqui BA, Singh P, Nagarajan A, et al. Immune checkpoint therapy\u2014current perspectives and future directions. Cell. 2023;186:1652\u201369.","journal-title":"Cell"},{"key":"1875_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","volume":"39","author":"A Bagati","year":"2021","unstructured":"Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, et al. Integrin \u03b1v\u03b26\u2013TGF\u03b2\u2013SOX4 pathway drives immune evasion in triple-negative breast cancer. Cancer Cell. 2021;39:54\u201367.e9.","journal-title":"Cancer Cell"},{"key":"1875_CR46","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s41573-022-00538-9","volume":"21","author":"R Offringa","year":"2022","unstructured":"Offringa R, K\u00f6tzner L, Huck B, Urbahns K. The expanding role for small molecules in immuno-oncology. Nat Rev Drug Discov. 2022;21:821\u201340.","journal-title":"Nat Rev Drug Discov"},{"key":"1875_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/cancers11040450","volume":"11","author":"S Daneshmandi","year":"2019","unstructured":"Daneshmandi S, Wegiel B, Seth P. Blockade of lactate dehydrogenase-A (LDH-A) improves efficacy of anti-programmed cell death-1 (PD-1) therapy in melanoma. Cancers. 2019;11:450.","journal-title":"Cancers"},{"key":"1875_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110986","volume":"39","author":"J Gu","year":"2022","unstructured":"Gu J, Zhou J, Chen Q, Xu X, Gao J, Li X, et al. Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-\u03b2 signaling in regulatory T cells. Cell Rep. 2022;39:110986.","journal-title":"Cell Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01875-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01875-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:31:59Z","timestamp":1785825119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01875-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":48,"alternative-id":["1875"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01875-w","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}